|
1
|
zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramqvist T, Grün N and Dalianis T: Human
papillomavirus and tonsillar and base of tongue cancer. Viruses.
7:1332–1343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lacey CJ, Lowndes CM and Shah KV: Chapter
4: Burden and management of non-cancerous HPV-related conditions:
HPV-6/11 disease. Vaccine. 24(Suppl 3): S3/35–41. 2006. View Article : Google Scholar
|
|
4
|
Cogliano V, Baan R, Straif K, Grosse Y,
Secretan B and El Ghissassi F; WHO International Agency for
Research on Cancer: Carcinogenicity of human papillomaviruses.
Lancet Oncol. 6:2042005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clifford GM, Smith JS, Plummer M, Muñoz N
and Franceschi S: Human papillomavirus types in invasive cervical
cancer worldwide: A meta-analysis. Br J Cancer. 88:63–73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mammas IN, Sourvinos G and Spandidos DA:
The paediatric story of human papillomavirus (Review). Oncol Lett.
8:502–506. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mammas IN, Vageli D and Spandidos DA:
Geographic variations of human papilloma virus infection and their
possible impact on the effectiveness of the vaccination programme.
Oncol Rep. 20:141–145. 2008.PubMed/NCBI
|
|
8
|
Workowski KA and Bolan GA; Centers for
Disease Control and Prevention: Sexually transmitted diseases
treatment guidelines, 2015. MMWR Recomm Rep. 64(No. RR-3): pp.
1–137. 2015
|
|
9
|
Workowski KA and Berman S; Centers for
Disease Control and Prevention (CDC): Sexually transmitted diseases
treatment guidelines, 2010. MMWR Recomm Rep. 59:1–110.
2010.PubMed/NCBI
|
|
10
|
de Villiers EM, Fauquet C, Broker TR,
Bernard HU and zur Hausen H: Classification of papillomaviruses.
Virology. 324:17–27. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stokley S, Jeyarajah J, Yankey D, Cano M,
Gee J, Roark J, Curtis RC and Markowitz L; Immunization Services
Division, National Center for Immunization and Respiratory
Diseases, CDC: Human papillomavirus vaccination coverage among
adolescents, 2007–2013, and postlicensure vaccine safety
monitoring, 2006–2014-United States. MMWR Morb Mortal Wkly Rep.
63:620–624. 2014.PubMed/NCBI
|
|
12
|
Chaturvedi AK, Engels EA, Pfeiffer RM,
Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M,
Cozen W, et al: Human papillomavirus and rising oropharyngeal
cancer incidence in the United States. J Clin Oncol. 29:4294–4301.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Castle PE, Schiffman M, Herrero R,
Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S,
Tarone R and Burk RD: A prospective study of age trends in cervical
human papillomavirus acquisition and persistence in Guanacaste,
Costa Rica. J Infect Dis. 191:1808–1816. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sedlacek TV, Lindheim S, Eder C, Hasty L,
Woodland M, Ludomirsky A and Rando RF: Mechanism for human
papillomavirus transmission at birth. Am J Obstet Gynecol.
161:55–59. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roman A and Fife K: Human papillomavirus
DNA associated with foreskins of normal newborns. J Infect Dis.
153:855–861. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rintala MA, Grénman SE, Järvenkylä ME,
Syrjänen KJ and Syrjänen SM: High-risk types of human
papillomavirus (HPV) DNA in oral and genital mucosa of infants
during their first 3 years of life: Experience from the Finnish HPV
Family Study. Clin Infect Dis. 41:1728–1733. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Boda D, Neagu M, Constantin C, Voinescu
RN, Caruntu C, Zurac S, Spandidos DA, Drakoulis N, Tsoukalas D and
Tsatsakis AM: HPV strain distribution in patients with genital
warts in a female population sample. Oncol Lett. 12:1779–1782.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen R, Sehr P, Waterboer T, Leivo I,
Pawlita M, Vaheri A and Aaltonen LM: Presence of DNA of human
papillomavirus 16 but no other types in tumor-free tonsillar
tissue. J Clin Microbiol. 43:1408–1410. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Powell J, Strauss S, Gray J and
Wojnarowska F: Genital carriage of human papilloma virus (HPV) DNA
in prepubertal girls with and without vulval disease. Pediatr
Dermatol. 20:191–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
De Marco F: Oxidative stress and HPV
carcinogenesis. Viruses. 5:708–731. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Căruntu C, Boda D, Musat S, Căruntu A and
Mandache E: Stress-induced mast cell activation in glabrous and
hairy skin. Mediators Inflamm. 2014:1059502014. View Article : Google Scholar :
|
|
22
|
Căruntu C, Grigore C, Căruntu A,
Diaconeasa A and Boda D: The role of stress in skin disease. Intern
Med. 8:73–84. 2003.
|
|
23
|
Fang CY, Miller SM, Bovbjerg DH, Bergman
C, Edelson MI, Rosenblum NG, Bove BA, Godwin AK, Campbell DE and
Douglas SD: Perceived stress is associated with impaired T-cell
response to HPV16 in women with cervical dysplasia. Ann Behav Med.
35:87–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View Article : Google Scholar
|
|
25
|
Gillison ML, Castellsagué X, Chaturvedi A,
Goodman MT, Snijders P, Tommasino M, Arbyn M and Franceschi S:
Eurogin Roadmap: Comparative epidemiology of HPV infection and
associated cancers of the head and neck and cervix. Int J Cancer.
134:497–507. 2014. View Article : Google Scholar
|
|
26
|
Giuliano AR, Nyitray AG, Kreimer AR,
Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J and
Franceschi S: EUROGIN 2014 roadmap: Differences in human
papillomavirus infection natural history, transmission and human
papillomavirus-related cancer incidence by gender and anatomic site
of infection. Int J Cancer. 136:2752–2760. 2015. View Article : Google Scholar
|
|
27
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gillison ML, Alemany L, Snijders PJ,
Chaturvedi A, Steinberg BM, Schwartz S and Castellsagué X: Human
papillomavirus and diseases of the upper airway: Head and neck
cancer and respiratory papillomatosis. Vaccine. 30(Suppl 5):
F34–F54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Doorbar J, Quint W, Banks L, Bravo IG,
Stoler M, Broker TR and Stanley MA: The biology and life-cycle of
human papillomaviruses. Vaccine. 30(Suppl 5): F55–F70. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sepiashvili L, Bruce JP, Huang SH,
O’Sullivan B, Liu FF and Kislinger T: Novel insights into head and
neck cancer using next-generation ‘omic’ technologies. Cancer Res.
75:480–486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Psyrri A, Rampias T and Vermorken JB: The
current and future impact of human papillomavirus on treatment of
squamous cell carcinoma of the head and neck. Ann Oncol.
25:2101–2115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ghita MA, Caruntu C, Lixandru D, Pitea A,
Batani A and Boda D: The quest for novel biomarkers in early
diagnosis of diabetic neuropathy. Curr Proteomics. 14:86–99. 2017.
View Article : Google Scholar
|
|
33
|
Hoadley KA, Yau C, Wolf DM, Cherniack AD,
Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov
V, et al Cancer Genome Atlas Research Network: Multiplatform
analysis of 12 cancer types reveals molecular classification within
and across tissues of origin. Cell. 158:929–944. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Termine N, Giovannelli L, Matranga D,
Caleca MP, Bellavia C, Perino A and Campisi G: Oral human
papillomavirus infection in women with cervical HPV infection: New
data from an Italian cohort and a metanalysis of the literature.
Oral Oncol. 47:244–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hakenberg OW, Compérat EM, Minhas S,
Necchi A, Protzel C and Watkin N; European Association of Urology:
EAU guidelines on penile cancer: 2014 update. Eur Urol. 67:142–150.
2015. View Article : Google Scholar
|
|
36
|
Lupu M, Caruntu A, Caruntu C, Papagheorghe
LML, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki
M, et al: Neuroendocrine factors: The missing link in non melanoma
skin cancer (Review). Oncol Rep. 38:1327–1340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Spiess PE, Dhillon J, Baumgarten AS,
Johnstone PA and Giuliano AR: Pathophysiological basis of human
papillomavirus in penile cancer: Key to prevention and delivery of
more effective therapies. CA Cancer J Clin. 66:481–495. 2016.
View Article : Google Scholar
|
|
38
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kayes O, Ahmed HU, Arya M and Minhas S:
Molecular and genetic pathways in penile cancer. Lancet Oncol.
8:420–429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Protzel C and Spiess PE: Molecular
research in penile cancer-lessons learned from the past and bright
horizons of the future? Int J Mol Sci. 14:19494–19505. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schiller JT, Day PM and Kines RC: Current
understanding of the mechanism of HPV infection. Gynecol Oncol.
118(Suppl): S12–S17. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Steben M and Duarte-Franco E: Human
papillomavirus infection: Epidemiology and pathophysiology. Gynecol
Oncol. 107(Suppl 1): S2–S5. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fuchs E and Nowak JA: Building epithelial
tissues from skin stem cells. Cold Spring Harb Symp Quant Biol.
73:333–350. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ledwaba T, Dlamini Z, Naicker S and Bhoola
K: Molecular genetics of human cervical cancer: Role of
papillomavirus and the apoptotic cascade. Biol Chem. 385:671–682.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Neagu M, Căruntu C, Constantin C, Boda D,
Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin
carcinogenesis: Updates in experimental models (Review). Oncol Rep.
35:2516–2528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Castellsagué X, Bosch FX and Muñoz N:
Environmental co-factors in HPV carcinogenesis. Virus Res.
89:191–199. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bosch FX and Muñoz N: The viral etiology
of cervical cancer. Virus Res. 89:183–190. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Satterwhite CL, Torrone E, Meites E, Dunne
EF, Mahajan R, Ocfemia MC, Su J, Xu F and Weinstock H: Sexually
transmitted infections among US women and men: Prevalence and
incidence estimates, 2008. Sex Transm Dis. 40:187–193. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nielsen A, Kjaer SK, Munk C and Iftner T:
Type-specific HPV infection and multiple HPV types: Prevalence and
risk factor profile in nearly 12,000 younger and older Danish
women. Sex Transm Dis. 35:276–282. 2008. View Article : Google Scholar
|
|
50
|
Skaaby S and Kofoed K: Anogenital warts in
Danish men who have sex with men. Int J STD AIDS. 22:214–217. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Owusu-Edusei K Jr, Chesson HW, Gift TL,
Tao G, Mahajan R, Ocfemia MC and Kent CK: The estimated direct
medical cost of selected sexually transmitted infections in the
United States, 2008. Sex Transm Dis. 40:197–201. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
World Health Organization: Implementation
of the global strategy for prevention and control of sexually
transmitted infections: 2006–2015. http://apps.who.int/iris/bitstream/10665/183117/1/9789241508841_eng.pdf.
Accessed Dec 21, 2015.
|
|
53
|
de Sanjosé S, Diaz M, Castellsagué X,
Clifford G, Bruni L, Muñoz N and Bosch FX: Worldwide prevalence and
genotype distribution of cervical human papillomavirus DNA in women
with normal cytology: A meta-analysis. Lancet Infect Dis.
7:453–459. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Newman L, Rowley J, Vander Hoorn S,
Wijesooriya NS, Unemo M, Low N, Stevens G, Gottlieb S, Kiarie J and
Temmerman M: Global estimates of the prevalence and incidence of
four curable sexually transmitted infections in 2012 based on
systematic review and global reporting. PLoS One. 10:e01433042015.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
McQuillan G, Kruszon-Moran D, Markowitz
LE, Unger ER and Paulose-Ram R: Prevalence of HPV in adults aged
18–69: United States, 2011–2014. NCHS Data Brief. (280): 1–8.
2017.PubMed/NCBI
|
|
56
|
Braaten KP and Laufer MR: Human
papillomavirus (HPV), HPV-related disease, and the HPV vaccine. Rev
Obstet Gynecol. 1:2–10. 2008.PubMed/NCBI
|
|
57
|
Dunne EF and Markowitz LE: Genital human
papillomavirus infection. Clin Infect Dis. 43:624–629. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Cai T, Wagenlehner FM, Mondaini N, D’Elia
C, Meacci F, Migno S, Malossini G, Mazzoli S and Bartoletti R:
Effect of human papillomavirus and Chlamydia trachomatis
co-infection on sperm quality in young heterosexual men with
chronic prostatitis-related symptoms. BJU Int. 113:281–287. 2014.
View Article : Google Scholar
|
|
59
|
Panatto D, Amicizia D, Bianchi S, Frati
ER, Zotti CM, Lai PL, Domnich A, Colzani D, Gasparini R and Tanzi
E: Chlamydia trachomatis prevalence and chlamydial/HPV co-infection
among HPV-unvaccinated young Italian females with normal cytology.
Hum Vaccin Immunother. 11:270–276. 2015. View Article : Google Scholar :
|
|
60
|
Smith JS, Muñoz N, Herrero R, Eluf-Neto J,
Ngelangel C, Franceschi S, Bosch FX, Walboomers JMM and Peeling RW:
Evidence for Chlamydia trachomatis as a human papillomavirus
cofactor in the etiology of invasive cervical cancer in Brazil and
the Philippines. J Infect Dis. 185:324–331. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tarallo PA, Smolowitz J, Carriero D,
Tarallo J, Siegel A, Jia H and Emond JC: Prevalence of high-risk
human papilloma virus among women with hepatitis C virus before
liver transplantation. Transpl Infect Dis. 15:400–404. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Smith JS, Herrero R, Bosetti C, Muñoz N,
Bosch FX, Eluf-Neto J, Castellsagué X, Meijer CJ, Van den Brule AJ,
Franceschi S and Ashley R; International Agency for Research on
Cancer (IARC) Multicentric Cervical Cancer Study Group: Herpes
simplex virus-2 as a human papillomavirus cofactor in the etiology
of invasive cervical cancer. J Natl Cancer Inst. 94:1604–1613.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Global Burden of Disease Study 2013
Collaborators: Global, regional, and national incidence,
prevalence, and years lived with disability for 301 acute and
chronic diseases and injuries in 188 countries, 1990–2013: A
systematic analysis for the Global Burden of Disease Study 2013.
Lancet. 386:743–800. 2013.
|
|
64
|
Alberts CJ, Schim van der Loeff MF,
Papenfuss MR, da Silva RJC, Villa LL, Lazcano-Ponce E, Nyitray AG
and Giuliano AR: Association of Chlamydia trachomatis infection and
herpes simplex virus type 2 serostatus with genital human
papillomavirus infection in men: The HPV in men study. Sex Transm
Dis. 40:508–515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mbulawa ZZ, Coetzee D, Marais DJ, Kamupira
M, Zwane E, Allan B, Constant D, Moodley JR, Hoffman M and
Williamson AL: Genital human papillomavirus prevalence and human
papillomavirus concordance in heterosexual couples are positively
associated with human immunodeficiency virus coinfection. J Infect
Dis. 199:1514–1524. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
66
|
Bruni L, Diaz M, Castellsagué X, Ferrer E,
Bosch FX and de Sanjosé S: Cervical human papillomavirus prevalence
in 5 continents: Meta-analysis of 1 million women with normal
cytological findings. J Infect Dis. 12:1789–1799. 2010. View Article : Google Scholar
|
|
67
|
Clifford GM, Gonçalves MA and Franceschi
S; HPV and HIV Study Group: Human papillomavirus types among women
infected with HIV: A meta-analysis. AIDS. 20:2337–2344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Koshiol J, Lindsay L, Pimenta JM, Poole C,
Jenkins D and Smith JS: Persistent human papillomavirus infection
and cervical neoplasia: A systematic review and meta-analysis. Am J
Epidemiol. 168:123–137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
van Rijn VM, Mooij SH, Mollers M, Snijders
PJF, Speksnijder AGCL, King AJ, de Vries HJ, van Eeden A, van der
Klis FR, de Melker HE, et al: Anal, penile, and oral high-risk HPV
infections and HPV seropositivity in HIV-positive and HIV-negative
men who have sex with men. PLoS One. 9:e922082014. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kjær SK, Frederiksen K, Munk C and Iftner
T: Long-term absolute risk of cervical intraepithelial neoplasia
grade 3 or worse following human papillomavirus infection: Role of
persistence. J Natl Cancer Inst. 102:1478–1488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Nielsen A, Kjaer SK, Munk C, Osler M and
Iftner T: Persistence of high-risk human papillomavirus infection
in a population-based cohort of Danish women. J Med Virol.
82:616–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Fukuchi E, Sawaya GF, Chirenje M, Magure
T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki
AB, et al: Cervical human papillomavirus incidence and persistence
in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis.
36:305–311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Paaso AE, Louvanto K, Syrjänen KJ,
Waterboer T, Grénman SE, Pawlita M and Syrjänen SM: Lack of
type-specific concordance between human papillomavirus (HPV)
serology and HPV DNA detection in the uterine cervix and oral
mucosa. J Gen Virol. 92:2034–2046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Syrjänen K, Shabalova I, Naud P,
Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C,
Nerovjna R, Longatto-Filho A, Kljukina L, et al New Independent
States of the Former Soviet Union and the Latin American Screening
Study Research Groups: Persistent high-risk human papillomavirus
infections and other end-point markers of progressive cervical
disease among women prospectively followed up in the New
Independent States of the Former Soviet Union and the Latin
American Screening study cohorts. Int J Gynecol Cancer. 19:934–942.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Syrjänen K, Shabalova I, Naud P,
Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C,
Nerovjna R, Longatto-Filho A, Kljukina L, et al; NIS and LAMS Study
Research Groups. Risk estimates for persistent high-risk human
papillomavirus infections as surrogate endpoints of progressive
cervical disease critically depend on reference category: Analysis
of the combined prospective cohort of the New Independent States of
the Former Soviet Union and Latin American Screening studies. Int J
STD AIDS. 22:315–323. 2011. View Article : Google Scholar
|
|
76
|
King EM, Gilson R, Beddows S, Soldan K,
Panwar K, Young C, Jit M, Edmunds WJ and Sonnenberg P: Oral human
papillomavirus (HPV) infection in men who have sex with men:
Prevalence and lack of anogenital concordance. Sex Transm Infect.
91:284–286. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lyronis ID, Baritaki S, Bizakis I,
Krambovitis E and Spandidos DA: K-ras mutation, HPV infection and
smoking or alcohol abuse positively correlate with esophageal
squamous carcinoma. Pathol Oncol Res. 14:267–273. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zaravinos A, Bizakis J and Spandidos DA:
Prevalence of human papilloma virus and human herpes virus types
1–7 in human nasal polyposis. J Med Virol. 81:1613–1619. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Du J, Nordfors C, Ahrlund-Richter A,
Sobkowiak M, Romanitan M, Näsman A, Andersson S, Ramqvist T and
Dalianis T: Prevalence of oral human papillomavirus infection among
youth, Sweden. Emerg Infect Dis. 18:1468–1471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Nielsen A, Kjaer SK, Munk C, Osler M and
Iftner T: Persistence of high-risk human papillomavirus infection
in a population-based cohort of Danish women. J Med Virol.
82:616–623. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Rosa MI, Fachel JM, Rosa DD, Medeiros LR,
Igansi CN and Bozzetti MC: Persistence and clearance of human
papillomavirus infection: A prospective cohort study. Am J Obstet
Gynecol. 199:617.e1–617.e7. 2008. View Article : Google Scholar
|
|
82
|
Koskimaa HM, Waterboer T, Pawlita M,
Grénman S, Syrjänen K and Syrjänen S: Human papillomavirus
genotypes present in the oral mucosa of newborns and their
concordance with maternal cervical human papillomavirus genotypes.
J Pediatr. 160:837–843. 2012. View Article : Google Scholar
|
|
83
|
Kofoed K, Sand C, Forslund O and Madsen K:
Prevalence of human papillomavirus in anal and oral sites among
patients with genital warts. Acta Derm Venereol. 94:207–211. 2014.
View Article : Google Scholar
|
|
84
|
Jang MK, Anderson DE, van Doorslaer K and
McBride AA: A proteomic approach to discover and compare
interacting partners of papillomavirus E2 proteins from diverse
phylogenetic groups. Proteomics. 15:2038–2050. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Yarbro CH, Wujcik D and Gobel BH: Cancer
Nursing: Principles and Practice. 7th. Jones & Bartlett;
Learning, Burlington, MA: 2010
|
|
86
|
Markowitz LE, Dunne EF, Saraiya M, Chesson
HW, Curtis CR, Gee J, Bocchini JA Jr and Unger ER; Centers for
Disease Control and Prevention (CDC): Human papillomavirus
vaccination: Recommendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR Recomm Rep. 63:1–30.
2014.PubMed/NCBI
|
|
87
|
Clifford GM, Rana RK, Franceschi S, Smith
JS, Gough G and Pimenta JM: Human papillomavirus genotype
distribution in low-grade cervical lesions: Comparison by
geographic region and with cervical cancer. Cancer Epidemiol
Biomarkers Prev. 14:1157–1164. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Clifford GM, Smith JS, Aguado T and
Franceschi S: Comparison of HPV type distribution in high-grade
cervical lesions and cervical cancer: A meta-analysis. Br J Cancer.
89:101–105. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Louvanto K, Rautava J, Willberg J, Wideman
L, Syrjänen K, Grénman S and Syrjänen S: Genotype-specific
incidence and clearance of human papillomavirus in oral mucosa of
women: A six-year follow-up study. PLoS One. 8:e534132013.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Wu DW, Chuang CY, Lin WL, Sung WW, Cheng
YW and Lee H: Paxillin promotes tumor progression and predicts
survival and relapse in oral cavity squamous cell carcinoma by
microRNA-218 targeting. Carcinogenesis. 35:1823–1829. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Martínez-Noël G, Galligan JT, Sowa ME,
Arndt V, Overton TM, Harper JW and Howley PM: Identification and
proteomic analysis of distinct UBE3A/E6AP protein complexes. Mol
Cell Biol. 32:3095–3106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
McBride AA: The papillomavirus E2
proteins. Virology. 445:57–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Jang MK, Shen K and McBride AA:
Papillomavirus genomes associate with BRD4 to replicate at fragile
sites in the host genome. PLoS Pathog. 10:e10041172014. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Bersani C, Mints M, Tertipis N, Haeggblom
L, Sivars L, Ährlund-Richter A, Vlastos A, Smedberg C, Grün N,
Munck-Wikland E, et al: A model using concomitant markers for
predicting outcome in human papillomavirus positive oropharyngeal
cancer. Oral Oncol. 68:53–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Grace M and Munger K: Proteomic analysis
of the gamma human papillomavirus type 197 E6 and E7 associated
cellular proteins. Virology. 500:71–81. 2017. View Article : Google Scholar
|
|
96
|
Serafín-Higuera I, Garibay-Cerdenares OL,
Illades-Aguiar B, Flores-Alfaro E, Jiménez-López MA,
Sierra-Martínez P and Alarcón-Romero LC: Differential proteins
among normal cervix cells and cervical cancer cells with HPV-16
infection, through mass spectrometry-based proteomics (2D-DIGE) in
women from Southern México. Proteome Sci. 14:102016. View Article : Google Scholar
|
|
97
|
Koifman L, Ornellas P, Ornellas AA,
Pereira DA, Zingali BR, Cavalcanti SM, Afonso LA, Sandim V and
Alves G: Proteomics analysis of tissue samples from patients with
squamous cell carcinoma of the penis and positive to human
papillomavirus. Int Braz J Urol. 41:642–654. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Tanase CP, Albulescu R and Neagu M:
Application of 3D hydrogel microarrays in molecular diagnostics:
Advantages and limitations. Expert Rev Mol Diagn. 11:461–464. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Ewaisha R, Meshay I, Resnik J, Katchman BA
and Anderson KS: Programmable protein arrays for immunoprofiling
HPV-associated cancers. Proteomics. 16:1215–1224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Arroyo Mühr LS, Hultin E, Bzhalava D,
Eklund C, Lagheden C, Ekström J, Johansson H, Forslund O and
Dillner J: Human papillomavirus type 197 is commonly present in
skin tumors. Int J Cancer. 136:2546–2555. 2015. View Article : Google Scholar
|
|
101
|
Dahlgren L, Mellin H, Wangsa D,
Heselmeyer-Haddad K, Björnestål L, Lindholm J, Munck-Wikland E,
Auer G, Ried T and Dalianis T: Comparative genomic hybridization
analysis of tonsillar cancer reveals a different pattern of genomic
imbalances in human papillomavirus-positive and −negative tumors.
Int J Cancer. 107:244–249. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Mountzios G, Rampias T and Psyrri A: The
mutational spectrum of squamous-cell carcinoma of the head and
neck: Targetable genetic events and clinical impact. Ann Oncol.
25:1889–1900. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Smeets SJ, Braakhuis BJ, Abbas S, Snijders
PJ, Ylstra B, van de Wiel MA, Meijer GA, Leemans CR and Brakenhoff
RH: Genome-wide DNA copy number alterations in head and neck
squamous cell carcinomas with or without oncogene-expressing human
papillomavirus. Oncogene. 25:2558–2564. 2006. View Article : Google Scholar
|
|
104
|
Hajek M, Sewell A, Kaech S, Burtness B,
Yarbrough WG and Issaeva N: TRAF3/CYLD mutations identify a
distinct subset of human papillomavirus-associated head and neck
squamous cell carcinoma. Cancer. 123:1778–1790. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Henderson S, Chakravarthy A, Su X, Boshoff
C and Fenton TR: APOBEC-mediated cytosine deamination links PIK3CA
helical domain mutations to human papillomavirus-driven tumor
development. Cell Reports. 7:1833–1841. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Lui VW, Hedberg ML, Li H, Vangara BS,
Pendleton K, Zeng Y, Lu Y, Zhang Q, Du Y, Gilbert BR, et al:
Frequent mutation of the PI3K pathway in head and neck cancer
defines predictive biomarkers. Cancer Discov. 3:761–769. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Kostareli E, Holzinger D, Bogatyrova O,
Hielscher T, Wichmann G, Keck M, Lahrmann B, Grabe N,
Flechtenmacher C, Schmidt CR, et al: HPV-related methylation
signature predicts survival in oropharyngeal squamous cell
carcinomas. J Clin Invest. 123:2488–2501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Lechner M, Fenton T, West J, Wilson G,
Feber A, Henderson S, Thirlwell C, Dibra HK, Jay A, Butcher L, et
al: Identification and functional validation of HPV-mediated
hypermethylation in head and neck squamous cell carcinoma. Genome
Med. 5:152013. View
Article : Google Scholar : PubMed/NCBI
|
|
109
|
de Lena PG, Paz-Gallardo A, Paramio JM and
García-Escudero R: Clusterization in head and neck squamous
carcinomas based on lncRNA expression: Molecular and clinical
correlates. Clin Epigenetics. 9:362017. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Jung AC, Briolat J, Millon R, de Reyniès
A, Rickman D, Thomas E, Abecassis J, Clavel C and Wasylyk B:
Biological and clinical relevance of transcriptionally active human
papillomavirus (HPV) infection in oropharynx squamous cell
carcinoma. Int J Cancer. 126:1882–1894. 2010.
|
|
111
|
Kimple RJ, Smith MA, Blitzer GC, Torres
AD, Martin JA, Yang RZ, Peet CR, Lorenz LD, Nickel KP, Klingelhutz
AJ, et al: Enhanced radiation sensitivity in HPV-positive head and
neck cancer. Cancer Res. 73:4791–4800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Seiwert TY, Zuo Z, Keck MK, Khattri A,
Pedamallu CS, Stricker T, Brown C, Pugh TJ, Stojanov P, Cho J, et
al: Integrative and comparative genomic analysis of HPV-positive
and HPV-negative head and neck squamous cell carcinomas. Clin
Cancer Res. 21:632–641. 2015. View Article : Google Scholar :
|
|
113
|
Gubanova E, Brown B, Ivanov SV, Helleday
T, Mills GB, Yarbrough WG and Issaeva N: Downregulation of SMG-1 in
HPV-positive head and neck squamous cell carcinoma due to promoter
hypermethylation correlates with improved survival. Clin Cancer
Res. 18:1257–1267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Lawrence MS, Sougnez C, Lichtenstein L,
Cibulskis K, Lander E, Gabriel SB, Getz G, Ally A, Balasundaram M,
Birol I, et al Cancer Genome Atlas Network: Comprehensive genomic
characterization of head and neck squamous cell carcinomas. Nature.
517:576–582. 2015. View Article : Google Scholar
|
|
115
|
Pyeon D, Newton MA, Lambert PF, den Boon
JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH,
Smith EM, et al: Fundamental differences in cell cycle deregulation
in human papillomavirus-positive and human papillomavirus-negative
head/neck and cervical cancers. Cancer Res. 67:4605–4619. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Lajer CB, Garnæs E, Friis-Hansen L,
Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D,
Skotte L, et al: The role of miRNAs in human papilloma virus
(HPV)-associated cancers: Bridging between HPV-related head and
neck cancer and cervical cancer. Br J Cancer. 106:1526–1534. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Slebos RJC, Jehmlich N, Brown B, Yin Z,
Chung CH, Yarbrough WG and Liebler DC: Proteomic analysis of
oropharyngeal carcinomas reveals novel HPV-associated biological
pathways. Int J Cancer. 132:568–579. 2013. View Article : Google Scholar
|
|
118
|
Colacino JA, Dolinoy DC, Duffy SA, Sartor
MA, Chepeha DB, Bradford CR, McHugh JB, Patel DA, Virani S, Walline
HM, et al: Comprehensive analysis of DNA methylation in head and
neck squamous cell carcinoma indicates differences by survival and
clinicopathologic characteristics. PLoS One. 8:e547422013.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Klussmann JP, Mooren JJ, Lehnen M,
Claessen SM, Stenner M, Huebbers CU, Weissenborn SJ, Wedemeyer I,
Preuss SF, Straetmans JM, et al: Genetic signatures of HPV-related
and unrelated oropharyngeal carcinoma and their prognostic
implications. Clin Cancer Res. 15:1779–1786. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Wilting SM, Smeets SJ, Snijders PJF, van
Wieringen WN, van de Wiel MA, Meijer GA, Ylstra B, Leemans CR,
Meijer CJLM, Brakenhoff RH, et al: Genomic profiling identifies
common HPV-associated chromosomal alterations in squamous cell
carcinomas of cervix and head and neck. BMC Med Genomics. 2:322009.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Canham M, Charsou C, Stewart J, Moncur S,
Hoodless L, Bhatia R, Cong D, Cubie H, Busby-Earle C, Williams A,
et al: Increased cycling cell numbers and stem cell associated
proteins as potential biomarkers for high grade human
papillomavirus+ve pre-neoplastic cervical disease. PLoS One.
9:e1153792014. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Van Raemdonck GAA, Tjalma WAA, Coen EP,
Depuydt CE and Van Ostade XWM: Identification of protein biomarkers
for cervical cancer using human cervicovaginal fluid. PLoS One.
9:e1064882014. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Descamps G, Wattiez R and Saussez S:
Proteomic study of HPV-positive head and neck cancers: Preliminary
results. BioMed Res Int. 2014:4309062014. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Bonner JA, Harari PM, Giralt J, Azarnia N,
Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, et al:
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head
and neck. N Engl J Med. 354:567–578. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Leung DT, Lim PL, Cheung TH, Wong RR, Yim
SF, Ng MH, Tam FC, Chung TK and Wong YF: Osteopontin fragments with
intact thrombin-sensitive site circulate in cervical cancer
patients. PLoS One. 11:e01604122016. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
De Marco F, Bucaj E, Foppoli C, Fiorini A,
Blarzino C, Filipi K, Giorgi A, Schininà ME, Di Domenico F, Coccia
R, et al: Oxidative stress in HPV-driven viral carcinogenesis:
Redox proteomics analysis of HPV-16 dysplastic and neoplastic
tissues. PLoS One. 7:e343662012. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Perluigi M, Giorgi A, Blarzino C, De Marco
F, Foppoli C, Di Domenico F, Butterfield DA, Schininà ME, Cini C
and Coccia R: Proteomics analysis of protein expression and
specific protein oxidation in human papillomavirus transformed
keratinocytes upon UVB irradiation. J Cell Mol Med. 13(8B):
1809–1822. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Overgaard J, Eriksen JG, Nordsmark M and
Alsner J; Danish Head and Neck Cancer Study Group:: Plasma
osteopontin, hypoxia, and response to the hypoxia sensitiser
nimorazole in radiotherapy of head and neck cancer: Results from
the DAHANCA 5 randomised double-blind placebo-controlled trial.
Lancet Oncol. 6:757–764. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Hassan Metwally MA, Jansen JA and
Overgaard J: Study of the population pharmacokinetic
characteristics of nimorazole in head and neck cancer patients
treated in the DAHANCA-5 trial. Clin Oncol (R Coll Radiol).
27:168–175. 2015. View Article : Google Scholar
|
|
130
|
Lee KA, Kang JW, Shim JH, Kho CW, Park SG,
Lee HG, Paik SG, Lim JS and Yoon DY: Protein profiling and
identification of modulators regulated by human papillomavirus 16
E7 oncogene in HaCaT keratinocytes by proteomics. Gynecol Oncol.
99:142–152. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Thomas M, Tomaić V, Pim D, Myers MP,
Tommasino M and Banks L: Interactions between E6AP and E6 proteins
from alpha and beta HPV types. Virology. 435:357–362. 2013.
View Article : Google Scholar
|
|
132
|
Sandberg A, Lindell G, Källström BN,
Branca RM, Danielsson KG, Dahlberg M, Larson B, Forshed J and
Lehtiö J: Tumor proteomics by multivariate analysis on individual
pathway data for characterization of vulvar cancer phenotypes. Mol
Cell Proteomics. 11:M112.0169982012. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Jamison JH, Kaplan DW, Hamman R, Eagar R,
Beach R and Douglas JM Jr: Spectrum of genital human papillomavirus
infection in a female adolescent population. Sex Transm Dis.
22:236–243. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Blas MM, Brown B, Menacho L, Alva IE,
Silva-Santisteban A and Carcamo C: HPV Prevalence in multiple
anatomical sites among men who have sex with men in Peru. PLoS One.
10:e01395242015. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Uzawa K, Baba T, Uchida F, Yamatoji M,
Kasamatsu A, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H and Tanzawa
H: Circulating tumor-derived mutant mitochondrial DNA: A predictive
biomarker of clinical prognosis in human squamous cell carcinoma.
Oncotarget. 3:670–677. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
No. 90-IARC Working Group on the
evaluation of carcinogenic risk to humans: IARC Monographs on the
evaluation of carcinogenic risks to humans. IARC; Lyon: 2007
|
|
137
|
Elrefaey S, Massaro MA, Chiocca S, Chiesa
F and Ansarin M: HPV in oropharyngeal cancer: The basics to know in
clinical practice. Acta Otorhinolaryngol Ital. 34:299–309.
2014.
|
|
138
|
Faridi R, Zahra A, Khan K and Idrees M:
Oncogenic potential of human papillomavirus (HPV) and its relation
with cervical cancer. Virol J. 8:2692011. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Hamana K, Uzawa K, Ogawara K, Shiiba M,
Bukawa H, Yokoe H and Tanzawa H: Monitoring of circulating
tumour-associated DNA as a prognostic tool for oral squamous cell
carcinoma. Br J Cancer. 92:2181–2184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Voiculescu V, Calenic B, Ghita M, Lupu M,
Caruntu A, Moraru L, Voiculescu S, Ion A, Greabu M, Ishkitiev N and
Caruntu C: From normal skin to squamous cell carcinoma: A quest for
novel biomarkers. Dis Markers. 2016:45174922016. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Stanescu B, Miron R and Badiu C:
Anaplastic carcinoma of the thyroid mimicking acute thyroiditis.
Acta Endocrinol (Bucur). 3:493–502. 2007. View Article : Google Scholar
|
|
143
|
Forastiere AA, Goepfert H, Maor M, Pajak
TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et
al: Concurrent chemotherapy and radiotherapy for organ preservation
in advanced laryngeal cancer. N Engl J Med. 349:2091–2098. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Pignon JP, le Maître A, Maillard E and
Bourhis J; MACH-NC Collaborative Group: Meta-analysis of
chemotherapy in head and neck cancer (MACH-NC): An update on 93
randomised trials and 17,346 patients. Radiother Oncol. 92:4–14.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Călina D, Docea AO, Roşu L, Zlatian O,
Roşu AF, Anghelina F, Rogoveanu O, Arsene AL, Nicolae AC, Drăgoi
CM, et al: Antimicrobial resistance development following surgical
site infections. Mol Med Rep. 15:681–688. 2017. View Article : Google Scholar :
|
|
146
|
Tănase A, Coliță A, Ianoşi G, Neagoe D,
Brănişteanu DE, Călina D, Docea AO, Tsatsakis A and Ianoşi SL: Rare
case of disseminated fusariosis in a young patient with graft vs.
host disease following an allogeneic transplant. Exp Ther Med.
12:2078–2082. 2016. View Article : Google Scholar :
|
|
147
|
Mioc M, Soica C, Bercean V, Avram S,
Balan-Porcarasu M, Coricovac D, Ghiulai R, Muntean D, Andrica F,
Dehelean C, et al: Design, synthesis and pharmaco-toxicological
assessment of 5-mercapto-1,2,4-triazole derivatives with
antibacterial and antiproliferative activity. Int J Oncol.
50:1175–1183. 2017. View Article : Google Scholar :
|
|
148
|
Oprean C, Borcan F, Pavel I, Dema A,
Danciu C, Soica C, Dehelean C, Nicu A, Ardelean A, Cristea M, et
al: In vivo biological evaluation of polyurethane nanostructures
with ursolic and oleanolic acids on chemically-induced skin
carcinogenesis. In Vivo. 30:633–638. 2016.PubMed/NCBI
|
|
149
|
Sani TA, Mohammadpour E, Mohammadi A,
Memariani T, Yazdi MV, Rezaee R, Calina D, Docea AO, Goumenou M,
Etemad L and Shahsavand S: Cytotoxic and apoptogenic properties of
Dracocephalum kotschyi aerial part different fractions on calu-6
and mehr-80 lung cancer cell lines. Farmacia. 65:189–199. 2017.
|
|
150
|
Suzich JA, Ghim SJ, Palmer-Hill FJ, White
WI, Tamura JK, Bell JA, Newsome JA, Jenson AB and Schlegel R:
Systemic immunization with papillomavirus L1 protein completely
prevents the development of viral mucosal papillomas. Proc Natl
Acad Sci USA. 92:11553–11557. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Roden RB, Monie A and Wu TC: Opportunities
to improve the prevention and treatment of cervical cancer. Curr
Mol Med. 7:490–503. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Joura EA, Leodolter S, Hernandez-Avila M,
Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW,
Ferris DG, et al: Efficacy of a quadrivalent prophylactic human
papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle
vaccine against high-grade vulval and vaginal lesions: A combined
analysis of three randomised clinical trials. Lancet.
369:1693–1702. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Varsani A, Williamson AL, de Villiers D,
Becker I, Christensen ND and Rybicki EP: Chimeric human
papillomavirus type 16 (HPV-16) L1 particles presenting the common
neutralizing epitope for the L2 minor capsid protein of HPV-6 and
HPV-16. J Virol. 77:8386–8393. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Paavonen J, Jenkins D, Bosch FX, Naud P,
Salmerón J, Wheeler CM, Chow SN, Apter DL, Kitchener HC,
Castellsague X, et al HPV PATRICIA study group: Efficacy of a
prophylactic adjuvanted bivalent L1 virus-like-particle vaccine
against infection with human papillomavirus types 16 and 18 in
young women: An interim analysis of a phase III double-blind,
randomised controlled trial. Lancet. 369:2161–2170. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Panatto D, Amicizia D, Bragazzi NL,
Rizzitelli E, Tramalloni D, Valle I and Gasparini R: Human
papillomavirus vaccine: State of the art and future perspectives.
Adv Protein Chem Struct Biol. 101:231–322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Toft L, Storgaard M, Müller M, Sehr P,
Bonde J, Tolstrup M, Østergaard L and Søgaard OS: Comparison of the
immunogenicity and reactogenicity of Cervarix and Gardasil human
papillomavirus vaccines in HIV-infected adults: A randomized,
double-blind clinical trial. J Infect Dis. 209:1165–1173. 2014.
View Article : Google Scholar
|
